Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

HOOKIPA Pharma Inc

HOOK
2,1101
-0,1899 (-8,26%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:09EDGAR2Form 8-K - Current report
14/11/202422:07EDGAR2Form 8-K - Current report
30/8/202414:04EDGAR2Form 8-K - Current report
08/8/202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:32EDGAR2Form 8-K - Current report
08/8/202422:30GLOBEHOOKIPA Pharma Reports Second Quarter 2024 Financial..
03/8/202400:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
26/7/202422:08EDGAR2Form 8-K - Current report
24/7/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202414:30GLOBEHOOKIPA Pharma Announces Leadership Changes to Intensify..
10/7/202413:00EDGAR2Form 8-K - Current report
08/7/202413:01GLOBEHOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse..
01/7/202422:31GLOBEHOOKIPA Pharma Announces First Person Dosed in Phase 1b..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:03EDGAR2Form 8-K - Current report
04/6/202422:15EDGAR2Form 8-K - Current report
04/6/202419:00GLOBEHOOKIPA Pharma Announces Updated Phase 2 Clinical Data at..
30/5/202422:30GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 Data..
23/5/202423:05EDGAR2Form 8-K - Current report
23/5/202423:01GLOBEHOOKIPA Pharma Announces Positive Clinical Data to be..
09/5/202413:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:03EDGAR2Form 8-K - Current report
09/5/202413:01GLOBEHOOKIPA Pharma Reports First Quarter 2024 Financial..
25/4/202413:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
24/4/202413:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
16/4/202422:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
10/4/202413:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
22/3/202412:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
06/3/202413:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
31/1/202422:30EDGAR2Form 8-K - Current report
29/1/202414:12EDGAR2Form 8-K - Current report
29/1/202414:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
16/1/202413:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202313:33EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202313:06EDGAR2Form 8-K - Current report
21/12/202313:01GLOBEHOOKIPA Pharma Announces $21.25 Million Equity Investment..
01/12/202322:46EDGAR2Form 8-K - Current report
Apertura: 2,34 Min: 2,08 Max: 2,38
Chiusura: 2,30

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network